Future ready workforce for post COVID decentralized clinical trials

The vaccines that are being steadily rolled out across the globe have raised significant hopes of the pandemic reaching a turning point. The pandemic provided the adrenaline rush to rapidly re-energize the organization, and to re-think methods that would facilitate decentralized clinical trials. Not only did it help consolidate our resources as a forward-looking company, but it has empowered our team to hone vital skills to stay resilient.

The clinical trial industry has witnessed major shifts that require a highly skilled and agile team to utilize the available resources with experience and expertise, to drive successful outcomes for clinical trials.

Navitas Life Sciences has been focusing on talent empowerment and re-skilling to stay ahead of the curve, which has helped in tiding over unprecedented times brought in by the pandemic. With February 11th celebrated as the International day for women and girls in Science, it is prudent to seek out how our diverse workforce with a strong sense of purpose embodies everything that our organization is known for.

Re-skilling and future perfect

In order to run efficient clinical trials, it is important to understand how clinical trials work and how they can be constantly enhanced. This requires frequent overhauling of the working system to stay in tune with changing times and the foresight to stay a few steps ahead!

1. Digital Health Tools and Artificial Intelligence (AI) Skills: The move to automate redundant and labor intensive tasks has helped in taking a consolidated step forward in increasing efficiency across various sectors. McKinsey statistics indicate that 39 to 58% of work activities across the world can be automated, with some industries moving ahead faster than others.

The traditional approach of increased dependence on manual labor and in person exchanges is no longer the way forward across many industries, with COVID-19 augmenting the need for rapid change. A report by Biospace states that Global automation in the healthcare market was valued in 2016 at US$28.31 bn and is set to rise to US$58.98 bn by the end of 2025.

According to a McKinsey report, 44% of respondents to a survey conducted said that their organization would face a skill gap within the next 5 years, while 43% said that their organization was already facing skill gaps. A future ready organization has to intentionally work towards bridging such skill gaps with innovation and enhanced productivity in mind.

At Navitas Life Sciences, there has been extensive investment in artificial intelligence and digital tools over the past few years, with concurrent upskilling of the team. Our significant shift and adoption of digital technology and artificial intelligence has re-affirmed our core purpose of working towards facilitating the faster reach of life saving drugs to the market

2. ‘Leading teams’ to ‘Leading as a team’: In 1854, the original organizational chart was developed to help build the New York and Erie railroad for a steam locomotive. Companies which have remained within such traditional strictures may find it difficult to adapt to changing needs. Though such hierarchical systems may have worked under certain circumstances, rapidly enhancing processes may be cumbersome and time consuming.

Utilizing such rigid structures in the current ecosystems is hard, it requires focus on creativity, accountability, and a purpose driven approach. Navitas Life Sciences cuts above the hierarchical approach, empowering our teams to be driven by the ‘why’ we work and for the numerous patients we help.

The learning environment helps foster a resilient fabric across the organization, which was brought to the fore during the recent pandemic mediated disruptions.

3. Global and accomplished team: In the Global ecosystem that has fast emerged over the years, it is important to have a diverse team to identify different perspectives and needs. There is a need to embrace diversity to better understand needs, with an onus on talent and greater effectiveness.

As the world celebrates International day of Women and Girls in Sciences, nearly 1/3rd of associates with a medical or science background at Navitas are women.

As we look ahead, we will continue to enact strategies, and utilize technology and capabilities, to carry out rigorous skill enhancement strategies using an empirical method. Armed with a common purpose of driving successful clinical trial outcomes, team members propel forward by sharpening their value agenda and expertise.

To know more about our services and solutions, or career opportunities, please reach out to This email address is being protected from spambots. You need JavaScript enabled to view it.

Insights from Our Regulatory & Pharmacovigilance E...
Oncology Clinical Trial Trends in 2021: Key Innova...

Solutions

Advisory Services

Clinical Development

Post Marketing

Therapeutics

Core Therapeutics

Interdisciplinary Therapeutics

Niche Therapeutics

Sectors

Governance

About Us